References
- Martínez-Baños D, Crispín JC, Lazo-Langner A, Sánchez-Guerrero J. Moderate and severe neutropenia in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2006; 45994–998.
- Hellmich B, Schnabel A, Gross WL. Treatment of severe neutropenia due to Felty’s syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor. Semin Arthritis Rheum. 1999; 2982–99.
- Frampton JE, Lee CR, Faulds D. Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs. 1994; 48731–760.
- Vasiliu IM, Petri MA, Baer AN. Therapy with granulocyte colony-stimulating factor in systemic lupus erythematosus may be associated with severe flares. J Rheumatol. 2006; 331878–1880.
- Euler HH, Schwab UM, Schroeder JO. Filgrastim for lupus neutropenia. Lancet. 1994; 3441513–1514.
- Euler HH, Harten P, Zeuner RA, Schwab UM. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections. J Rheumatol. 1997; 242153–2157.
- Gottenberg JE, Roux S, Desmoulins F, Clerc D, Mariette X. Granulocyte colony-stimulating factor therapy resulting in a flare of systemic lupus erythematosus: comment on the article by Yang and Hamilton. Arthritis Rheum. 2001; 442458–2460.
- Eyles JL, Roberts AW, Metcalf D, Wicks IP. Granulocyte colony-stimulating factor and neutrophils–forgotten mediators of inflammatory disease. Nat Clin Pract Rheumatol. 2006; 2500–510.
- Rutella S. Granulocyte colony-stimulating factor for the induction of T-cell tolerance. Transplantation. 2007; 84S26–S30.
- Campbell IK, Rich MJ, Bischof RJ, Hamilton JA. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol. 2000; 68144–150.
- Lawlor KE, Campbell IK, Metcalf D, O’Donnell K, Nieuwenhuijze A, Roberts AW, et al. Critical role for granulocyte colony-stimulating factor in inflammatory arthritis. Proc Natl Acad Sci USA. 2004; 10111398–11403.
- Eyles JL, Hickey MJ, Norman MU, Croker BA, Roberts AW, Drake SF, et al. A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. Blood. 2008; 1125193–5201.
- Costner MI, Sontheimer RD. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Lupus Erythematosus. Fitzpatrick’s Dermatology in General Medicine. 7th ed. New York: McGraw-Hill; 2007. p. 1515–1535.
- Shiohara T, Kurata M, Mizukawa Y, Kano Y. Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruptions and those under immunosuppressive therapy. Allergol Int.. 2010; 59333–343.
- Chandesris MO, Kelaidi C, Mechai F, Bougnoux ME, Brousse N, Viard JP, et al. Granulocyte colony stimulating factor-induced exacerbation of fungus-related immune restoration inflammatory syndrome: a case of chronic disseminated candidiasis exacerbation. J Microbiol Immunol Infect. 2010; 43339–343.